Unique Wealth Strategies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$832K Buy
3,306
+596
+22% +$128K 0.3% 81
2026
Q1
$589K Sell
2,710
-52
-2% -$11.5K 0.24% 114
2025
Q4
$631K Buy
+2,762
New +$629K 0.25% 113
2025
Q3
Sell
-3,337
Closed -$619K 212
2025
Q2
$619K Buy
+3,337
New +$620K 0.26% 105
2024
Q3
Sell
-2,637
Closed -$480K 202
2024
Q2
$480K Hold
2,637
0.23% 129
2024
Q1
$480K Buy
+2,637
New +$454K 0.24% 129

Other funds holding ABBV

Unique Wealth Strategies's ABBV Position: Q2 2026 in Review

Unique Wealth Strategies increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $128K and bringing the position to 3,306 shares worth $832K. The position accounts for 0.3% of the portfolio, ranked #81.

Unique Wealth Strategies first reported a position in ABBV in Q1 2024 and has held it in 6 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Unique Wealth Strategies held 3,306 shares of AbbVie worth $832K as of Q2 2026.
  • Unique Wealth Strategies bought 596 AbbVie shares in Q2 2026, an estimated $128K.
  • AbbVie made up 0.3% of Unique Wealth Strategies's portfolio in Q2 2026, its #81 holding.
  • Unique Wealth Strategies first reported a position in AbbVie in Q1 2024 and has held it in 6 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.